XML 31 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cash Equivalents and Marketable Securities
12 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Marketable Securities
4. Cash Equivalents and Marketable Securities
The following tables summarize the estimated fair value of the Company’s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):
 
    
December 31, 2023
 
    
Amortized

Cost
    
Gross

Unrealized

Gains
    
Gross

Unrealized

Losses
    
Estimated

Fair Value
 
Cash equivalents:
           
Money market funds
   $ 150,648      $ —       $ —       $ 150,648  
Commercial paper
     24,950        5        —         24,955  
U.S. government treasury securities
     10,965        1        —         10,966  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total cash equivalents
     186,563        6        —         186,569  
  
 
 
    
 
 
    
 
 
    
 
 
 
Marketable securities:
           
Commercial paper
     79,124        62        —         79,186  
Corporate bonds
     32,984        81        (1      33,064  
U.S. government treasury securities
     21,846        31        —         21,877  
U.S. government agency securities
     16,147        110        —         16,257  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 150,101      $ 284      $ (1    $ 150,384  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2022
 
    
Amortized

Cost
    
Gross

Unrealized

Gains
    
Gross

Unrealized

Losses
    
Estimated

Fair Value
 
Cash equivalents:
                   
Money market funds
   $ 15,250      $ —       $ —       $ 15,250  
Commercial paper
     7,021        1        (2      7,020  
U.S. government agency securities
     3,736        —         (1      3,735  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total cash equivalents
   $ 26,007      $ 1      $ (3    $ 26,005  
  
 
 
    
 
 
    
 
 
    
 
 
 
Marketable securities:
           
Commercial paper
   $ 16,644      $ 2      $ (25    $ 16,621  
Corporate bonds
     3,738        —         (6      3,732  
U.S. government agency securities
     495        —         —         495  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $  20,877      $ 2      $ (31    $  20,848  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
The following table summarizes the
available-for-sale
securities in an unrealized loss position for which an allowance for credit losses has not been recorded as of December 31, 2023 and 2022, aggregated by major security type and length of time in a continuous unrealized loss position:
 
    
December 31, 2023
 
    
Less Than 12 Months
   
12 Months or Longer
    
Total
 
    
Fair Value
    
Unrealized

Losses
   
Fair Value
    
Unrealized

Losses
    
Fair Value
    
Unrealized

Losses
 
Commercial paper
   $ —       $ —      $ —       $ —       $ —       $ —   
Corporate bonds
     9,907        (1     —         —         9,907        (1
U.S. government treasury securities
     4,831        —        —         —         4,831        —   
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 14,738      $ (1   $ —       $ —       $ 14,738      $ (1
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2022
 
    
Less Than 12 Months
   
12 Months or Longer
    
Total
 
    
Fair Value
    
Unrealized

Losses
   
Fair Value
    
Unrealized

Losses
    
Fair Value
    
Unrealized

Losses
 
Commercial paper
   $ 17,699      $ (27   $ —       $ —       $ 17,699      $ (27
Corporate bonds
     3,732        (6     —         —         3,732        (6
U.S. government agency securities
     3,735        (1     —         —         3,735        (1
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
Total marketable securities
   $ 25,166      $ (34   $ —       $ —       $ 25,166      $ (34
  
 
 
    
 
 
   
 
 
    
 
 
    
 
 
    
 
 
 
The Company evaluated its securities for credit losses and considered the decline in market value to be primarily attributable to current economic and market conditions and not to a credit loss or other factors. Additionally, the Company does not intend to sell the securities in an unrealized loss position and does not expect they will be required to sell the securities before recovery of the unamortized cost basis. As of December 31, 2023 and 2022, an allowance for credit losses had
not
been recognized. Given the Company’s intent and ability to hold such securities until recovery, and the lack of significant change in credit risk of these investments, the Company does not consider these marketable securities to be impaired as of December 31, 2023 and 2022.
There were $0.3 million unrealized gains on marketable securities for the year ended December 31, 2023. There were no realized gains on marketable securities for the year ended December 31, 2023, 2022 and 2021. Interest on marketable securities is included in interest income. Accrued interest receivable on
available-for-sale
debt
securities
totaled $0.9 million and $0.1 million as of December 31, 2023 and 2022, respectively, and is excluded from the estimate of credit losses.
The following table summarizes the contractual maturities of the Company’s marketable securities at estimated fair value (in thousands):
 
    
December 31,
 
    
2023
    
2022
 
Due in one year or less
   $ 115,784      $ 20,848  
Due in 1 – 2 years
     34,600        —   
  
 
 
    
 
 
 
Total marketable securities
   $ 150,384      $ 20,848  
  
 
 
    
 
 
 
The Company may sell investments at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies marketable securities, including securities with maturities beyond twelve months as current assets.